A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer (Q42596227)
Jump to navigation
Jump to search
scientific article published on 4 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer |
scientific article published on 4 April 2011 |
Statements
1 reference
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer (English)
1 reference
1 reference
M Krzakowski
1 reference
J Jassem
1 reference
C Manegold
1 reference
A Szczesna
1 reference
P Zatloukal
1 reference
J S K Au
1 reference
M Blasinska-Morawiec
1 reference
P Serwatowski
1 reference
E H Tan
1 reference
R J Benner
1 reference
A Ingrosso
1 reference
S J Meech
1 reference
D Readett
1 reference
N Thatcher
1 reference
4 April 2011
1 reference
1 reference
23
1 reference
1
1 reference
72-77
1 reference
Identifiers
1 reference
1 reference